In this interview Andrea Manfrin, Deputy Director of Clinical Investigations and Trials at the MHRA, offers thoughtful advice for emerging leaders in AI/ML.
Biopharm Report
Industry Statisticians Discuss Influence on Regulatory Guidance, Policies
Meijing Wu and Di Zhang—editors of the Biopharmaceutical Report—interview Ivan Chan from BMS and Bill Wang from Merck about the impact of regulatory guidance/policies in driving statistical innovation.
Innovation in Statistics and Regulatory Science Through Collaboration: A Journey
Biostatistician Margaret Gamalo says innovation in statistics and regulatory science involves incremental progress, requires the engagement of various stakeholders, and often unfolds in a nonlinear manner.